Latest Blog Posts Tagged "Translational Stage"
August 24, 2016
To keep you informed of the Foundation's research investments, we're highlighting a few newly funded grants supporting the development of therapies to address common non-motor symptoms of Parkinson's.
December 23, 2013
The SURE-PD study published in JAMA Neurology reports that with medical supervision, it is possible to safely raise levels of the antioxidant urate by taking the urate precursor inosine.
November 22, 2013
A study The Michael J. Fox Foundation funded earlier this year is looking for participants to test a treatment for dyskinesia.
December 21, 2012
Today at Forbes, pharma reporter Matt Herper is summing up "Ten Lessons on Fighting Disease from Michael J. Fox." The post recaps his conversation with Michael J. Fox and Debi Brooks.
September 19, 2012
Ten biopharmaceutical companies today announced that they would collaborate to build a new nonprofit organization designed to accelerate drug development.
September 14, 2012
The Michael J. Fox Foundation for Parkinson's Research's (MJFF) CEO, Todd Sherer, PhD has been selected to sit on The National Center for Advancing Translational Sciences (NCATS) Advisory Council.
June 08, 2012
Forbes offers some troubling stats on the economics of drug development. The good news: The story focuses on pharma giant (and MJFF partner) Sanofi's efforts to revitalize translational medicine.
April 13, 2012
NIH head Francis Collins, who provided colorful illustrations for how to accelerate translational research in drug development, to bring novel drugs to the people that need them, faster.
The Puzzling Status of Statins: How Can Cholesterol Drugs Prevent Parkinson's, But Cause Alzheimer's-like Disease?
March 16, 2012
This week, competing reports on cholesterol lowering drugs called statins, and the effects they have on the brains of those who take them, have popped up in the press.